An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know

Transaction summary

Transaction worth based connected SEC Form 4 weighted mean merchantability terms ($249.16); post-transaction worth based connected July 29, 2026 marketplace adjacent ($247.56).

Key questions

• What is the standard of the executive's remaining equity interest?
  Following this 19% simplification successful nonstop holdings, Eric Sherbet maintains a presumption of 20,999 shares. This remaining involvement is valued astatine ~$5.2 cardinal based connected the July 29, 2026 marketplace adjacent of $247.56.

• What are the existent fiscal fundamentals for IQVIA Holdings?
  The institution generated $17.0 cardinal successful gross and $1.4 cardinal successful nett income implicit the trailing 12 months. As of the July 30, 2026 marketplace close, the banal was priced astatine $237.82, supporting a marketplace capitalization of $38.8 billion.

• How is the institution positioned wrong the healthcare sector?
  IQVIA Holdings is simply a planetary supplier of analytical insights and exertion solutions for the beingness sciences industry, operating done segments including Technology & Analytics Solutions and Research & Development Solutions.

Company Overview

Company Snapshot

• IQVIA provides blase analytical insights, precocious exertion solutions, and broad objective probe services to the beingness sciences industry, with superior gross streams derived from its Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions segments.

• The institution operates a diversified concern exemplary that generates gross done information analytics platforms, objective proceedings absorption services, real-world grounds solutions, and declaration income unit deployment, serving arsenic an indispensable infrastructure supplier crossed the pharmaceutical, biotechnology, and aesculapian instrumentality sectors.

• IQVIA's superior customers see pharmaceutical manufacturers, biotechnology firms, aesculapian instrumentality companies, and healthcare providers crossed the Americas, Europe, Africa, and Asia-Pacific, positioning the institution arsenic a captious spouse successful cause development, commercialization, and healthcare analytics.

IQVIA Holdings Inc. is simply a starring planetary supplier of integrated solutions for the beingness sciences industry, employing professionals crossed aggregate continents. The institution leverages proprietary information assets, precocious analytics capabilities, and extended objective probe infrastructure to present mission-critical services that accelerate cause improvement and optimize commercialized outcomes for its clients. With a marketplace capitalization of $38.8 cardinal and TTM gross of $17.0 billion, IQVIA maintains a competitory vantage done its broad level approach, combining technology, data, and quality expertise to code analyzable challenges successful pharmaceutical improvement and healthcare commercialization.